10 Nov Lavipharm at CPhI Worldwide 2022 – «At the heart of Pharma»
Peania, 10 November 2022 – Lavipharm once again participated in CPhI Worldwide 2022, the largest exhibition in the pharmaceutical industry worldwide and the meeting point for thousands of pharma professionals from all over the globe. The live exhibition took place from 1 to 3 November in Frankfurt, Germany, with the digital version available online from 28 September through 18 November 2022.
More than 2,500 exhibitors from 170 countries attended CPhI Worldwide to discuss and learn about current developments in the pharmaceutical industry. After two years of strict restrictions due to the pandemic, CPhI saw a significant increase in the number of participants, mainly from countries outside Europe.
Lavipharm took part in CPhI Worldwide 2022 as an exhibitor, and its booth attracted a large number of visitors. The Lavipharm team advised visitors about the group’s integrated portfolio of products and services, mainly focusing on its expertise in transdermal delivery systems. This area is a major competitive advantage for Lavipharm, which has one of the few plants globally with lines dedicated to producing transdermal systems that have been exported internationally for 3 decades.
“Our participation in CPhI Worldwide 2022 was once again an important opportunity for Lavipharm to successfully communicate the quality of its pharmaceutical products, the continuous expansion of its portfolio and the know-how it possesses from its many years of experience. We renew our appointment for next year in Barcelona, at CPhI Worldwide 2023,” said Mr. Panagiotis Giannouleas, Chief Operating Officer & Country Manager of Lavipharm.
With a history of 111 years, Lavipharm is today an integrated Greek pharmaceutical Group of research, development, production, marketing and distribution in Greece, with strong international activity.